Douglas Robert Andrew 4

What Happened
Douglas Robert Andrew, a director of Globus Medical, was granted a derivative award of 15,000 stock options on January 21, 2026. The grant is reported at a $0.00 acquisition price on the Form 4 (derivative award); the filing identifies these as options and shows no immediate cash value.

Key Details

• Transaction date: January 21, 2026; Form 4 filed January 23, 2026 (filed within the typical 2-business-day window).
• Security/amount: 15,000 share-based options (derivative award) at $0.00 reported price.
• Vesting: Footnote states the options were granted Jan 21, 2026 and will vest on January 1, 2027.
• Shares owned after transaction: not specified in the provided filing excerpt.
• No 10b5-1, tax-withholding, cashless exercise, or sale information was reported for this transaction.

Context
This transaction is a grant of options (a common form of executive/director compensation) rather than an open-market purchase or sale. Grants do not necessarily indicate immediate buying or selling pressure and typically vest over time before the holder can exercise or sell shares. There is no indication in the filing that any shares were sold or exercised in connection with this grant.